Direct Flow Medical® Transcatheter Aortic Valve System

The Direct Flow Medical system is designed to treat aortic stenosis with minimal risk of aortic regurgitation, a significant clinical complication with current transcatheter aortic heart valve replacement (TAVR) systems. By reducing the risks of TAVR, the Direct Flow Medical system is designed to improve the long-term outcomes of patients undergoing this procedure.

The system’s unique design encompasses a distinctive metal-free valve frame and flexible, low-profile delivery system, which enables limitless repositionability and repeated assessment of full hemodynamic performance before final implantation.

The information on this site is only intended for health care providers in certain markets outside the United States (US) where the Direct Flow Medical Trancatheter Aortic Valve Replacement System is approved for use as indicated by the instructions for use. The information on this page is not intended for health care providers in the US or US health care institutions as this site contains information about a product that is limited by US law to investigational use.

I am a health care
provider in the
United States
I am a health care
provider outside
the United States